McDiarmid et al developed the Pediatric End-Stage Liver Disease (PELD) model to help evaluate children with end-stage liver disease. This can help identify patients for liver transplantation.
(2) serum albumin in g/dL
(3) serum total bilirubin in mg/dL
(4) International Normalized Ratio (INR)
(5) height (and growth failure)
age in years
< 1 year of age
>= 1 year of age
height > 2 standard deviations below mean for age (Z score < -2)
height <= 2 standard deviations below mean for age
PELD score =
= 10 * ((0.463 * (points for age)) + (0.667 * (points for growth failure)) - (0.687 * LN(albumin)) + (0.480 * LN(total bilirubin)) + (1.857 * LN(INR)))
• LN = natural logarithm, base e
To read more or access our algorithms and calculators, please log in or register.
Purpose: To evaluate the Pediatric End-Stage Liver Disease (PELD) score for a pediatric patient with advanced liver disease.
Objective: other testing, severity, prognosis, stage, selection
ICD-10: Z94.4, K72.1,